Literature DB >> 23687409

Cathelicidin a potential therapeutic peptide for gastrointestinal inflammation and cancer.

Jimmy Yip Chuen Chow1, Zhi Jie Li, William Ka Kei Wu, Chi Hin Cho.   

Abstract

Cathelicidins, are host defense peptides synthesized and stored in circulating leukocytes and numerous types of epithelial tissues in particular the gastrointestinal (GI) tract and skin. They have been known for their antimicrobial activities against a variety of microbes. Recently it was discovered that they have other significant biological functions and produce appealing pharmacological actions against inflammation and cancer in the GI tract through defined mechanisms. Experimental evidence shows that these actions could be tissue and disease specific and concentration dependent. This article reviews some of the physiological functions of cathelicidins and also their therapeutic potential in the treatment of inflammation and cancer and also the delivery system for this peptide as targeted therapy for various disorders in the GI tract both in animals and humans.

Entities:  

Keywords:  Cancer; Cathelicidin; Gastrointestinal tract; Inflammation; Ulcer repair

Mesh:

Substances:

Year:  2013        PMID: 23687409      PMCID: PMC3653146          DOI: 10.3748/wjg.v19.i18.2731

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  39 in total

1.  Apoptosis of airway epithelial cells: human serum sensitive induction by the cathelicidin LL-37.

Authors:  Y Elaine Lau; Dawn M E Bowdish; Celine Cosseau; Robert E W Hancock; Donald J Davidson
Journal:  Am J Respir Cell Mol Biol       Date:  2005-12-09       Impact factor: 6.914

2.  Mechanisms of cell death induced by the neutrophil antimicrobial peptides alpha-defensins and LL-37.

Authors:  J Aarbiou; G S Tjabringa; R M Verhoosel; D K Ninaber; S R White; L T C Peltenburg; K F Rabe; P S Hiemstra
Journal:  Inflamm Res       Date:  2006-03       Impact factor: 4.575

Review 3.  Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies.

Authors:  Robert E W Hancock; Hans-Georg Sahl
Journal:  Nat Biotechnol       Date:  2006-12       Impact factor: 54.908

4.  Syndecans, cell surface heparan sulfate proteoglycans, are induced by a proline-rich antimicrobial peptide from wounds.

Authors:  R L Gallo; M Ono; T Povsic; C Page; E Eriksson; M Klagsbrun; M Bernfield
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-08       Impact factor: 11.205

5.  Antimicrobial protein hCAP18/LL-37 is highly expressed in breast cancer and is a putative growth factor for epithelial cells.

Authors:  Johan D Heilborn; Margareta Frohm Nilsson; Clara I Chamorro Jimenez; Bengt Sandstedt; Niels Borregaard; Emma Tham; Ole E Sørensen; Günther Weber; Mona Ståhle
Journal:  Int J Cancer       Date:  2005-05-01       Impact factor: 7.396

6.  Heterogeneous expression of human cathelicidin hCAP18/LL-37 in inflammatory bowel diseases.

Authors:  Jürgen Schauber; Daniel Rieger; Frank Weiler; Jan Wehkamp; Matthias Eck; Klaus Fellermann; Wolfgang Scheppach; Richard L Gallo; Eduard F Stange
Journal:  Eur J Gastroenterol Hepatol       Date:  2006-06       Impact factor: 2.566

7.  C-terminal domain of human CAP18 antimicrobial peptide induces apoptosis in oral squamous cell carcinoma SAS-H1 cells.

Authors:  Kazuhiko Okumura; Akifumi Itoh; Emiko Isogai; Kimiharu Hirose; Yoichiro Hosokawa; Yoshihiro Abiko; Takatoshi Shibata; Michimasa Hirata; Hiroshi Isogai
Journal:  Cancer Lett       Date:  2004-08-30       Impact factor: 8.679

8.  Expression of LL-37 by human gastric epithelial cells as a potential host defense mechanism against Helicobacter pylori.

Authors:  Koji Hase; Masamoto Murakami; Mitsutoshi Iimura; Sheri P Cole; Yoshimune Horibe; Takaaki Ohtake; Marygorret Obonyo; Richard L Gallo; Lars Eckmann; Martin F Kagnoff
Journal:  Gastroenterology       Date:  2003-12       Impact factor: 22.682

9.  An angiogenic role for the human peptide antibiotic LL-37/hCAP-18.

Authors:  Rembert Koczulla; Georges von Degenfeld; Christian Kupatt; Florian Krötz; Stefan Zahler; Torsten Gloe; Katja Issbrücker; Pia Unterberger; Mohamed Zaiou; Corinna Lebherz; Alexander Karl; Philip Raake; Achim Pfosser; Peter Boekstegers; Ulrich Welsch; Pieter S Hiemstra; Claus Vogelmeier; Richard L Gallo; Matthias Clauss; Robert Bals
Journal:  J Clin Invest       Date:  2003-06       Impact factor: 14.808

Review 10.  Cathelicidins, multifunctional peptides of the innate immunity.

Authors:  Margherita Zanetti
Journal:  J Leukoc Biol       Date:  2003-07-22       Impact factor: 4.962

View more
  9 in total

Review 1.  Role of the gastrointestinal ecosystem in the development of type 1 diabetes.

Authors:  Joseph G Daft; Robin G Lorenz
Journal:  Pediatr Diabetes       Date:  2015-05-08       Impact factor: 4.866

2.  Identification and Characterization of the First Cathelicidin from Sea Snakes with Potent Antimicrobial and Anti-inflammatory Activity and Special Mechanism.

Authors:  Lin Wei; Jiuxiang Gao; Shumin Zhang; Sijin Wu; Zeping Xie; Guiying Ling; Yi-Qun Kuang; Yongliang Yang; Haining Yu; Yipeng Wang
Journal:  J Biol Chem       Date:  2015-05-26       Impact factor: 5.157

3.  The antimicrobial peptides LL-37, KR-20, FK-13 and KR-12 inhibit the growth of a sensitive and a metronidazole-resistant strain of Trichomonas vaginalis.

Authors:  María G Ramírez-Ledesma; Mayra C Rodríguez; Nayeli Alva-Murillo; Eva E Avila
Journal:  Parasitol Res       Date:  2022-09-29       Impact factor: 2.383

4.  Cathelicidin LL-37 improves bone metabolic balance in rats with ovariectomy-induced osteoporosis via the Wnt/beta-catenin pathway.

Authors:  J Liang; J Chen; Z Ye; D Bao
Journal:  Physiol Res       Date:  2022-05-26       Impact factor: 2.139

Review 5.  The Role of Antimicrobial Peptides as Antimicrobial and Antibiofilm Agents in Tackling the Silent Pandemic of Antimicrobial Resistance.

Authors:  Bruno S Lopes; Alfizah Hanafiah; Ramesh Nachimuthu; Saravanan Muthupandian; Zarith Nameyrra Md Nesran; Sandip Patil
Journal:  Molecules       Date:  2022-05-06       Impact factor: 4.927

6.  Polymorphisms of Genes Related to Function and Metabolism of Vitamin D in Esophageal Adenocarcinoma.

Authors:  Saurabh Singhal; Harit Kapoor; Saravanan Subramanian; Devendra K Agrawal; Sumeet K Mittal
Journal:  J Gastrointest Cancer       Date:  2019-12

7.  HAPPENN is a novel tool for hemolytic activity prediction for therapeutic peptides which employs neural networks.

Authors:  Patrick Brendan Timmons; Chandralal M Hewage
Journal:  Sci Rep       Date:  2020-07-02       Impact factor: 4.379

Review 8.  Discovery of modulators of HIV-1 infection from the human peptidome.

Authors:  Jan Münch; Ludger Ständker; Wolf-Georg Forssmann; Frank Kirchhoff
Journal:  Nat Rev Microbiol       Date:  2014-08-11       Impact factor: 60.633

9.  Tumor imaging and targeting potential of an Hsp70-derived 14-mer peptide.

Authors:  Mathias Gehrmann; Stefan Stangl; Gemma A Foulds; Rupert Oellinger; Stephanie Breuninger; Roland Rad; Alan G Pockley; Gabriele Multhoff
Journal:  PLoS One       Date:  2014-08-28       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.